Another study on primary human glioblastoma cell lines derived from resected patients and co-cultured with matched autologous T cells demonstrated high T cell apoptosis upon contact with PTEN-deficient cancer cells, indicating that PTEN-deficient glioblastoma patients are suboptimal candidates for immunotherapy. This evidence concerns the gene PTEN and glioblastoma.